found that tumor-cell-independent estrogen signaling enhanced pSTAT3 activity through transcriptional upregulation of JAK2 and increased total STAT3 expression in myeloid progenitors and therefore drove disease progression through mobilization of myeloid-derived suppressor cells (50). This evidence concerns the gene STAT3 and neoplasm.